Mothers' and fathers' views of family management and health-related quality of life for young adult survivors of childhood brain tumors.

Purpose: To examine associations between fathers' and mothers' appraisals of family management and physical and emotional health-related quality of life (QOL) for young adult survivors of childhood brain tumors.

Design: Cross-sectional.

Sample: 47 mothers and 39 fathers (39-67 years old); 47 survivors (18-33 years old).

Hydroxyurea in Pediatric Patients With Sickle Cell Disease: What Nurses Need to Know.

Sickle cell disease (SCD) is an inherited disorder in which sickled red blood cells occlude the small vessels of the body, reducing oxygen delivery to tissues and ultimately negatively affecting many of the body's major organs. Hydroxyurea has proven beneficial in the treatment of SCD and prevention of disease-related complications. The 2014 guidelines put forth by the National Heart, Lung, and Blood Institute recommend hydroxyurea treatment in infants 9 months and older, children, and adolescents with SCD-SS or SCD-Sβ(0) thalassemia regardless of clinical severity.